
Analysts Downgrade Tourmaline Bio Stock After Novartis Acquisition
Both Jefferies and Wedbush have downgraded Tourmaline Bio's stock rating to Hold following its acquisition by Novartis. The analysts express concerns regarding the future performance of Tourmaline Bio under the new ownership, indicating a cautious outlook for the company.

Analysts Downgrade Tourmaline Bio Stock After Novartis Acquisition
Both Jefferies and Wedbush have downgraded Tourmaline Bio's stock rating to Hold following its acquisition by Novartis. The analysts express concerns regarding the future performance of Tourmaline Bio under the new ownership, indicating a cautious outlook for the company.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system have analyzed 4,828 articles worldwide
That's roughly 201 articles per hour
534 trending stories shaping headlines worldwide
From breaking news to viral moments
AI-driven monitoring of 200 trusted sources, nonstop
From major news outlets to specialized publications
The latest update landed just 33 minutes ago
We never sleep, so you're always informed
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system have analyzed 4,828 articles worldwide
That's roughly 201 articles per hour
534 trending stories shaping headlines worldwide
From breaking news to viral moments
AI-driven monitoring of 200 trusted sources, nonstop
From major news outlets to specialized publications
The latest update landed just 33 minutes ago
We never sleep, so you're always informed
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more